Lisa Mosconi
#105,030
Most Influential Person Now
Italian American neuroscientist
Lisa Mosconi's AcademicInfluence.com Rankings
Lisa Mosconibiology Degrees
Biology
#14257
World Rank
#17965
Historical Rank
Neuroscience
#2577
World Rank
#2647
Historical Rank
Download Badge
Biology
Lisa Mosconi's Degrees
- PhD Neuroscience University of Florence
- Masters Psychology University of Florence
Why Is Lisa Mosconi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lisa Mosconi is an Italian American neuroscientist, educator, and author known for her books The XX Brain and Brain Food. She is the Director of the Women’s Brain Initiative and Director of the Alzheimer’s Prevention Clinic, both at Weill Cornell Medical College where she is an Associate Professor of Neuroscience in Neurology.
Lisa Mosconi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease (2014) (1634)
- Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease (2005) (774)
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias (2008) (669)
- Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease (2008) (474)
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease (2009) (411)
- MCI conversion to dementia and the APOE genotype (2004) (354)
- Reduced hippocampal metabolism in MCI and AD (2005) (323)
- Sleep-disordered breathing advances cognitive decline in the elderly (2015) (301)
- Hippocampal hypometabolism predicts cognitive decline from normal aging (2008) (297)
- Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease (2008) (273)
- Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal (2010) (268)
- Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment (2006) (260)
- Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. (2006) (259)
- The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease (2008) (249)
- Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. (2010) (242)
- Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism (2007) (234)
- Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints (2008) (229)
- Glucose metabolism in normal aging and Alzheimer’s disease: methodological and physiological considerations for PET studies (2013) (214)
- Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease (2007) (201)
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment (2009) (185)
- Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease (2009) (181)
- Periodontal disease associates with higher brain amyloid load in normal elderly (2015) (173)
- Early detection of Alzheimer’s disease using neuroimaging (2007) (165)
- Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults (2018) (153)
- Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study (2017) (135)
- Nutrient patterns and brain biomarkers of Alzheimer’s disease in cognitively normal individuals (2015) (126)
- Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer’s (2010) (126)
- Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. (2013) (122)
- Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. (2014) (114)
- Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly. (2016) (114)
- Sex differences in Alzheimer risk (2017) (106)
- Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study (2008) (103)
- The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals (2014) (102)
- Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. (2014) (95)
- Female Sex and Alzheimer’s Risk: The Menopause Connection (2018) (95)
- Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery (2017) (90)
- Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study (2018) (86)
- The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease (2009) (85)
- Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET (2006) (85)
- Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease (2004) (82)
- Longitudinal CSF isoprostane and MRI atrophy in the progression to AD (2007) (81)
- Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. (2011) (81)
- PET/CT in diagnosis of dementia (2011) (79)
- Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies (2009) (79)
- Maternal transmission of Alzheimer's disease: Prodromal metabolic phenotype and the search for genes (2010) (77)
- Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. (2008) (76)
- Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease. (2004) (73)
- Sex and Gender Driven Modifiers of Alzheimer’s: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks (2019) (72)
- Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study (2014) (70)
- Framingham Cardiovascular Risk Profile Correlates with Impaired Hippocampal and Cortical Vasoreactivity to Hypercapnia (2011) (68)
- Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. (2009) (66)
- Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly (2014) (66)
- A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice (2008) (65)
- Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly (2012) (65)
- Metabolic interaction between ApoE genotype and onset age in Alzheimer’s disease: implications for brain reserve (2004) (65)
- 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease (2007) (60)
- Early Detection of Alzheimer’s Disease with PET Imaging (2010) (55)
- Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents (2013) (54)
- Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. (2008) (53)
- Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study (2014) (53)
- The clinical practice of risk reduction for Alzheimer’s disease: A precision medicine approach (2018) (53)
- Structural brain changes in normal individuals with a maternal history of Alzheimer's (2011) (52)
- Sex-driven modifiers of Alzheimer risk (2020) (52)
- PET/CT in diagnosis of movement disorders (2011) (51)
- Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau (2019) (50)
- Transient and chronic seizure‐induced inflammation in human focal epilepsy (2016) (49)
- Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition (2021) (48)
- Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease (2007) (47)
- Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area (2018) (47)
- Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis. (2009) (46)
- Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders (2011) (45)
- Individualized clinical management of patients at risk for Alzheimer's dementia (2019) (45)
- FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? (2011) (44)
- Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD (2014) (43)
- Dissociation of Down syndrome and Alzheimer's disease effects with imaging (2016) (43)
- Oxidative Stress and Amyloid-Beta Pathology in Normal Individuals with A Maternal History of Alzheimer's (2010) (42)
- Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study (2004) (41)
- Magnetic resonance and PET studies in the early diagnosis of Alzheimer’s disease (2004) (41)
- Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects. (2016) (40)
- Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia. (2013) (37)
- The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease. (2005) (36)
- Clinical Application of APOE in Alzheimer’s Prevention: A Precision Medicine Approach (2018) (36)
- FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease (2014) (32)
- Brain metabolic differences between sporadic and familial Alzheimer’s disease (2003) (29)
- Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia (2018) (28)
- Reduced retention of Pittsburgh compound B in white matter lesions (2014) (28)
- Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter (2014) (27)
- Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention (2018) (27)
- Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects (2016) (27)
- Associations of lifestyle and vascular risk factors with Alzheimer’s brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area (2018) (26)
- Toward the Validation of Functional Neuroimaging as a Potential Biomarker for Alzheimer’s Disease: Implications for Drug Development (2005) (22)
- Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease. (2007) (21)
- Prefrontal N-acetylaspartate and poststroke recovery: a longitudinal proton spectroscopy study. (2007) (21)
- Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly. (2013) (21)
- Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease (2015) (20)
- Precision Medicine for Alzheimer’s Disease Prevention (2018) (20)
- Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. (2012) (17)
- Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers’ Risk of Alzheimer’s Disease (2015) (16)
- Brain: Normal Variations and Benign Findings in FDG PET/CT imaging (2014) (16)
- Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife (2021) (15)
- Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease (2012) (15)
- Metabolic correlates of executive dysfunction (2007) (14)
- Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms (2013) (14)
- An entorhinal cortex sulcal pattern is associated with Alzheimer's disease (2009) (13)
- Role of Nutrition to Promote Healthy Brain Aging and Reduce Risk of Alzheimer’s Disease (2017) (12)
- The concept of FDG-PET endophenotype in Alzheimer’s disease (2011) (12)
- Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention (2022) (12)
- Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery (2018) (11)
- Using social media to disseminate education about Alzheimer’s prevention & treatment: a pilot study on Alzheimer's Universe (www.AlzU.org) (2018) (10)
- Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients (2020) (10)
- Seeing what Alzheimer saw (2007) (9)
- A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer’s prevention & treatment (2021) (8)
- Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer’s disease (2022) (8)
- FDG PET in the Evaluation of Mild Cognitive Impairment and Early Dementia (2009) (8)
- Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology. (2009) (7)
- A tale of two tracers: Glucose metabolism and amyloid positron emission tomography imaging in Alzheimer's disease (2011) (6)
- How would we combat menopause as an Alzheimer’s risk factor? (2018) (6)
- Positron Emission Tomography in Alzheimer Disease: Diagnosis and Use as Biomarker Endpoints (2012) (5)
- Cerebrospinal fluid biomarkers for mild cognitive impairment (2006) (4)
- Characterizing brain amyloid changes using PiB-PET: Progression, clinical correlates, PiB status and optimized sampling (2012) (3)
- O2-03-04 Hypometabolism and altered CSF markers in normal APOE E4 carriers with subjective memory complaints (2007) (3)
- Evaluation of Early Dementia (Mild Cognitive Impairment). (2010) (3)
- Brain Glucose Metabolism: Age, Alzheimer’s Disease, and ApoE Allele Effects (2009) (2)
- Sex-Driven Differences in the Effectiveness of Individualized Clinical Management of Alzheimer’s Disease Risk (2022) (2)
- Positron emission tomography in Alzheimer’s disease: early prediction and differentiation (2009) (2)
- PET Scans Obtained for Evaluation of Cognitive Dysfunction (2015) (2)
- Neuropathological and Neuroimaging Studies of the Hippocampus in Normal Aging and in Alzheimer’s Disease (2011) (2)
- Imaging Alzheimer's disease: The evolution of biomarkers (2015) (1)
- The Early Detection of Alzheimer's Disease with Positron Emission Tomography (2009) (1)
- Sex and menopause impact 31P-Magnetic Resonance Spectroscopy brain mitochondrial function in association with 11C-PiB PET amyloid-beta load (2022) (1)
- The interaction between sleep-disordered breathing and ApoE genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly (2014) (1)
- Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease (2011) (1)
- Reduced brain glucose metabolism in hypertension (2014) (1)
- A Clinical Precision Medicine Approach Reduces Alzheimer’s, Dementia and Vascular Risk and Improves Cognition: A Prospective Cohort Study (P6.085) (2017) (1)
- Use of PIB-PET in a double-blind, placebo-controlled Alzheimer's disease (AD) immunotherapy trial (2008) (1)
- When an amyloid PET threshold of 1.5 becomes 1.4 and longitudinal accumulation is not what it appears: Interpreting and reconciling values amidst scanner variability (2012) (1)
- P1-269: Maternal history of Alzheimer's disease predisposes to progressive brain hypometabolism on FDG-PET (2008) (1)
- Differences in hippocampal metabolism between amnestic and non-amnestic MCI: Automated FDG-PET image analysis (2006) (0)
- In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical Symptomatology (2023) (0)
- Framigham cardiovascular risk profile correlates with impaired hippocampal and cortical perfusion (2010) (0)
- Cerebellar reference region quality control and analysis as a critical aspect of PET amyloid measurement (2012) (0)
- Regional cerebral glucose metabolism provides a sensitive and specific marker of Alzheimer's disease, frontotemporal dementia and mild cognitive impairment, and correlates with cerebrospinal fluid Abeta42 level decline in cognitively normal subjects (2010) (0)
- Effects of metabolic syndrome, antihypertensive medications, and statins on PiB deposition in cognitively normal subjects (2015) (0)
- P3-070: CSF Total tau and gray matter density in Alzheimer's disease–specific brain regions: A study of normal aging (2008) (0)
- When an amyloid PET threshold of 1.5 becomes 1.4 and longitudinal accumulation is not what it appears: Interpreting and reconciling values amidst scanner variability (2012) (0)
- Hippocampal glucose metabolism predicts cognitive decline and correlates to disease progression in the ADNI population (2009) (0)
- A multivariate glucose metabolism metric for patient stratification and prediction of cognitive decline in Alzheimer's disease clinical trials (2012) (0)
- Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer’s disease: A 31Phosphorus MR spectroscopy study (2023) (0)
- Acceleration of regional brain loss during progression of Alzheimer’s disease (2005) (0)
- EANM Springer Prizes 2009 Awarded (2009) (0)
- Imaging the hippocampal formation in the early diagnosis of Alzheimer’s disease (2005) (0)
- Hippocampal metabolic reductions in mild cognitive impairment and Alzheimer’s disease: Automated FDG-PET image analysis (2005) (0)
- Brain Hypometabolism, Oxidative Stress, Maternal Transmission, and Risk of Late-Onset Alzheimer’s Disease (2013) (0)
- Normotensive elderly with white matter lesions: A group at risk for Alzheimer's disease (2015) (0)
- P2-152 Basal frontal/temporal hypometabolism and depressive symptoms in highly educated Alzheimer's disease patients (2004) (0)
- Longitudinal reduction in blood pressure in hypertensive individuals is associated with increased levels of biomarkers for Alzheimer's disease (2012) (0)
- Night-to-night variability in sleep-disordered breathing and glucose hypometabolism in cognitively normal elderly (2013) (0)
- Brain amyloid imaging: the challenge of the third millennium. (2011) (0)
- P3-067: MRI brain atrophy and CSF biomarkers predict decline to Alzheimer's disease in mild cognitive impairment (2008) (0)
- P2-314 Hypometabolism precedes volume loss in presymptomatic individuals with early-onset familial Alzheimer’s disease (2006) (0)
- A multivariate glucose metabolism metric for patient stratification and prediction of cognitive decline in Alzheimer's disease clinical trials (2012) (0)
- The Paradox of Precision Medicine (2020) (0)
- P2-252 Reductions in brain glucose metabolism as correlates and predictors of cognitive decline from normal aging (2006) (0)
- MRI and FDG-PET changes in normal aging across the adult lifespan (2013) (0)
- The spectrum of FDG-PET changes in brain glucose metabolism from normal aged to pathologically verified dementia subjects (2007) (0)
- Presence of the APOE-ε4 allele decreases fertility in men but not women (2012) (0)
- IC-P-047 Brain glucose metabolism: A lifespan view (2006) (0)
- Quantitative structural MRI and CSF biomarkers in early diagnosis of Alzheimer's disease (2011) (0)
- Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer’s disease (2022) (0)
- TRANSITIONS OF THE AGING FEMALE BRAIN: WINDOW INTO UNDERLYING MECHANISMS OF LATE ONSET ALZHEIMER’S DISEASE (2018) (0)
- Increased Amyloid-β-related Hypometabolism in Cognitively Normal Individuals with Late-onset Alzheimer's Affected Parents (2010) (0)
- Emission Tomography Scans btained for the Evaluation of Cognitive Dysfunction (0)
- PRECISION MEDICINE INTERVENTION IN PATIENTS AT RISK FOR ALZHEIMER'S DEMENTIA (2019) (0)
- Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau (2019) (0)
- Maternal history and impaired memory predict decline to dementia in cognitively normal individuals (2012) (0)
- Correlations between amyloid and metabolic pet imaging in cognitively normal adults with a family history of late-onset Alzheimer's disease (2011) (0)
This paper list is powered by the following services:
Other Resources About Lisa Mosconi
What Schools Are Affiliated With Lisa Mosconi?
Lisa Mosconi is affiliated with the following schools:
